Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(100.0%)

3Total

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06503393Completed

SENOVIE France - Therapeutic Mobility and Breast Cancer

Role: collaborator

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT06952829Not ApplicableNot Yet Recruiting

Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access

Role: lead

NCT06443320Not ApplicableRecruiting

Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

Role: lead

NCT05520151Not ApplicableRecruiting

Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies

Role: lead

NCT04365764Completed

Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study

Role: collaborator

NCT04366206Unknown

Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est

Role: lead

NCT01162538Unknown

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

Role: lead

All 8 trials loaded